Dr. Lal Path Labs share price
Dr. Lal Path Labs Ltd. · NSE: LALPATHLAB · Healthcare
Price, one year
Price range
- Open
- ₹1,839.00
- High
- ₹1,854.60
- Low
- ₹1,801.20
- Previous close
- ₹1,843.70
- Volume
- 1.2 L
- Market cap
- ₹30,854 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- 56.6
- Price to book
- 12.3
- Return on equity
- 21.6%
- EPS (TTM)
- ₹32.45
- Book value / share
- ₹149.43
- Debt to equity
- 0.00
- Revenue (TTM)
- ₹2,891 Cr
- Net profit (TTM)
- ₹542 Cr
- Sales growth, YoY
- +19.1%
- Profit growth, YoY
- +28.0%
- Operating margin
- 29.0%
- Net margin
- 18.8%
- Sales CAGR, 3 years
- +11.1%
- Profit CAGR, 3 years
- +28.3%
- Promoter holding
- 52.93%
- Promoter shares pledged
- 0.00%
Shareholding pattern
% of shares| Holder | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 53.21 | 53.19 | 52.93 |
| Foreign institutions | 17.18 | 17.36 | 18.73 |
| Domestic institutions | 21.38 | 21.59 | 21.58 |
| Mutual funds | 18.62 | 18.79 | 18.68 |
| Retail and others | 6.55 | 6.25 | 5.29 |
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 24 Jul 2026. results: 4 Nov 2026.
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,748.00 | −0.57% |
| Divi's LaboratoriesDIVISLAB | ₹8,950.00 | −2.31% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,524.40 | −1.97% |
| Zydus LifesciencesZYDUSLIFE | ₹1,129.40 | −0.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,730.00 | +1.65% |
| CiplaCIPLA | ₹1,338.00 | +0.53% |
| Laurus LabsLAURUSLABS | ₹1,970.00 | −1.62% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,229.50 | −0.77% |
| Mankind PharmaMANKIND | ₹2,212.60 | −2.77% |
| Aurobindo PharmaAUROPHARMA | ₹1,571.70 | −2.43% |
Frequently asked questions
What is the share price of Dr. Lal Path Labs today?
Dr. Lal Path Labs (NSE: LALPATHLAB) was at ₹1,838.20 on 23 Oct 2026, a change of −0.30% from the previous close.
What are the 52-week high and low of Dr. Lal Path Labs?
Over the last 52 weeks Dr. Lal Path Labs traded between ₹1,272.60 and ₹2,038.60 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Dr. Lal Path Labs?
About ₹30,854 Cr at the latest price, with a P/E of 56.6, a price-to-book of 12.3, a return on equity of 21.6%. Ratios use the company's latest reported results.
Who owns Dr. Lal Path Labs shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 52.93%, foreign institutions 18.73%, domestic institutions 21.58%.
Which sector and indices does Dr. Lal Path Labs belong to?
NSE classifies Dr. Lal Path Labs under Healthcare; it is a member of Nifty 500.
Follow Dr. Lal Path Labs with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Start free trial